A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer’s disease

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · see citing works

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · see citing works

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · see citing works

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049 · see citing works

Neuropathology of older persons without cognitive impairment from two community-based studies

Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · see citing works

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001 · see citing works

Neuropathology of Cognitively Normal Elderly

Knopman, D. S., Parisi, J. E., Salviati, A., Floriach-Robert, M., Boeve, B. F., Ivnik, R. J., Smith, G. E., Dickson, D. W., Johnson, K. A., Petersen, L. E., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.11.1087 · Cited by 674 · see citing works

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · see citing works

Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

Bai, B., Wang, X., Li, Y., Chen, P.-C., Yu, K., Dey, K. K., Yarbro, J. M., Han, X., Lutz, B. M., Rao, S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.015 · Cited by 632 · see citing works

Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level

Johnson, E. C. B., Carter, E. K., Dammer, E. B., Duong, D. M., Gerasimov, E. S., Liu, Y., Liu, J., Betarbet, R., Ping, L., Yin, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00999-y · Cited by 561 · see citing works

A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease

Mostafavi, S., Gaiteri, C., Sullivan, S. E., White, C. C., Tasaki, S., Xu, J., Taga, M., Klein, H.-U., Patrick, E., Komashko, V., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0154-9 · Cited by 509 · see citing works

A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease

Seyfried, N. T., Dammer, E. B., Swarup, V., Nandakumar, D., Duong, D. M., Yin, L., Deng, Q., Nguyen, T., Hales, C. M., Wingo, T., et al. (2017) · Cell Systems · doi:10.1016/j.cels.2016.11.006 · Cited by 477 · see citing works

Amyloid biomarkers in Alzheimer's disease

Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.002 · Cited by 470 · see citing works

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Villemagne, V. L., Doré, V., Burnham, S. C., Masters, C. L., & Rowe, C. C. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2018.9 · Cited by 440 · see citing works

Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies

Zetterberg, H., & Bendlin, B. B. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0721-9 · Cited by 379 · see citing works

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease

Higginbotham, L., Ping, L., Dammer, E. B., Duong, D. M., Zhou, M., Gearing, M., Hurst, C., Glass, J. D., Factor, S. A., Johnson, E. C. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz9360 · Cited by 367 · see citing works

Developing the ATX(N) classification for use across the Alzheimer disease continuum

Hampel, H. J., Cummings, J. L., Blennow, K., Gao, P., Jack, C. R., & Vergallo, A. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00520-w · Cited by 331 · see citing works

Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia

Jack, C. R., Wiste, H. J., Therneau, T. M., Weigand, S. D., Knopman, D. S., Mielke, M. M., Lowe, V. J., Vemuri, P., Machulda, M. M., Schwarz, C. G., et al. (2019) · JAMA · doi:10.1001/jama.2019.7437 · Cited by 324 · see citing works

NPTX2 and cognitive dysfunction in Alzheimer’s Disease

Xiao, M.-F., Xu, D., Craig, M. T., Pelkey, K. A., Chien, C.-C., Shi, Y., Zhang, J., Resnick, S., Pletnikova, O., Salmon, D., et al. (2017) · eLife · doi:10.7554/elife.23798 · Cited by 316 · see citing works

Molecular subtyping of Alzheimer’s disease using RNA sequencing data reveals novel mechanisms and targets

Neff, R. A., Wang, M., Vatansever, S., Guo, L., Ming, C., Wang, Q., Wang, E., Horgusluoglu-Moloch, E., Song, W.-M., Li, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb5398 · Cited by 306 · see citing works

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

Bader, J. M., Geyer, P. E., Müller, J. B., Strauss, M. T., Koch, M., Leypoldt, F., Koertvelyessy, P., Bittner, D., Schipke, C. G., Incesoy, E. I., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199356 · Cited by 286 · see citing works

Pentraxins Coordinate Excitatory Synapse Maturation and Circuit Integration of Parvalbumin Interneurons

Pelkey, K. A., Barksdale, E., Craig, M. T., Yuan, X., Sukumaran, M., Vargish, G. A., Mitchell, R. M., Wyeth, M. S., Petralia, R. S., Chittajallu, R., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.020 · Cited by 245 · see citing works

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age

Wingo, A. P., Dammer, E. B., Breen, M. S., Logsdon, B. A., Duong, D. M., Troncosco, J. C., Thambisetty, M., Beach, T. G., Serrano, G. E., Reiman, E. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09613-z · Cited by 211 · see citing works

Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain

Wingo, A. P., Fan, W., Duong, D. M., Gerasimov, E. S., Dammer, E. B., Liu, Y., Harerimana, N. V., White, B., Thambisetty, M., Troncoso, J. C., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0635-5 · Cited by 161 · see citing works

14-3-3 proteins in neurological disorders.

Foote, M. M., & Zhou, Y. (2012) · PubMed · Cited by 140 · see citing works

14-3-3 Proteins in Brain Development: Neurogenesis, Neuronal Migration and Neuromorphogenesis

Cornell, B., & Toyo‐oka, K. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00318 · Cited by 140 · see citing works

Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease

Zhou, M., Haque, R. U., Dammer, E. B., Duong, D. M., Ping, L., Johnson, E. C. B., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2020) · Clinical Proteomics · doi:10.1186/s12014-020-09285-8 · Cited by 92 · see citing works

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Visser, P. J., Reus, L. M., Gobom, J., Jansen, I. E., Dicks, E., van der Lee, S. J., Tsolaki, M., Verhey, F. R. J., Popp, J., Martínez‐Lage, P., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00521-3 · Cited by 88 · see citing works

Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

Bai, B., Wang, X., Li, Y., Chen, P.-C., Yu, K., Dey, K. K., Yarbro, J. M., Han, X., Lutz, B. M., Rao, S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.04.031 · Cited by 78 · see citing works

Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease

Watson, C. M., Dammer, E. B., Ping, L., Duong, D. M., Modeste, E. S., Carter, E. K., Johnson, E. C. B., Levey, A. I., Lah, J. J., Roberts, B. R., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02158-3 · Cited by 58 · see citing works

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Binette, A. P., Gaiteri, C., Wennström, M., Kumar, A., Hristovska, I., Spotorno, N., Salvadó, G., Strandberg, O. T., Mathys, H., Tsai, L., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01737-w · Cited by 130 · see citing works

CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease

Shen, Y., Timsina, J., Heo, G., Beric, A., Ali, M., Wang, C., Yang, C., Wang, Y., Western, D., Liu, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.049 · Cited by 75 · see citing works

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease

Guo, Y. X., Chen, S.-D., You, J., Huang, S.-Y., Chen, Y., Zhang, Y., Wang, L., He, X., Deng, Y., Zhang, Y.-R., et al. (2024) · Nature Human Behaviour · doi:10.1038/s41562-024-01924-6 · Cited by 65 · see citing works

A hybrid multimodal machine learning model for Detecting Alzheimer's disease

Sheng, J., Zhang, Q., Zhang, Q., Wang, L., Yang, Z. X., Yu, X., & Wang, B. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108035 · Cited by 53 · see citing works

Sleep deprivation leads to non-adaptive alterations in sleep microarchitecture and amyloid-β accumulation in a murine Alzheimer model

Cankar, N., Beschörner, N., Tsopanidou, A., Qvist, F. L., Colaço, A. R., Andersen, M., Kjærby, C., Delle, C., Lambert, M., Mundt, F., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114977 · Cited by 42 · see citing works

ADNI Biomarker Core: A review of progress since 2004 and future challenges

Shaw, L. M. J., Korecka, M., Lee, E. B., Cousins, K. A. Q., Vanderstichele, H., Schindler, S. E., Tosun, D., DeMarco, M. L., Brylska, M., Wan, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14264 · Cited by 35 · see citing works

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Balcomb, K., Johnston, C., Kavanagh, T., Leitner, D., Schneider, J. A., Halliday, G. M., Wısnıewskı, T., Sunde, M., & Drummond, E. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02819-6 · Cited by 32 · see citing works

Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease

Guo, Q. J., Ping, L., Dammer, E. B., Duong, D. M., Yin, L., Xu, K., Shantaraman, A., Fox, E. J., Golde, T. E., Johnson, E. C. B., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00757-1 · Cited by 37 · see citing works

Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients

Vervuurt, M., Schrader, J. M., de Kort, A. M., Kersten, I., Wessels, H. J. C. T., Klijn, C. J. M., Schreuder, F. H. B. M., Kuiperij, H. B., Gloerich, J., Nostrand, W. E. V., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01698-4 · Cited by 26 · see citing works

Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer’s disease

Vilkaite, G., Vogel, J. W., & Mattsson, N. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101735 · Cited by 25 · see citing works

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Shantaraman, A., Dammer, E. B., Ugochukwu, O., Duong, D. M., Yin, L., Carter, E. K., Gearing, M., Chen‐Plotkin, A. S., Lee, E. B., Trojanowski, J. Q., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00749-1 · Cited by 22 · see citing works

Immunotherapy: An emerging treatment option for neurodegenerative diseases

Mukherjee, A., Biswas, S., & Roy, I. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103974 · Cited by 21 · see citing works

NEK7 induces lactylation in Alzheimer’s disease to promote pyroptosis in BV-2 cells

Cheng, J., & Zhao, H. (2024) · Molecular Brain · doi:10.1186/s13041-024-01156-9 · Cited by 19 · see citing works

A positron emission tomography tracer for the imaging of oxidative stress in the central nervous system

Wilde, J. H., Sun, Y., Simpson, S. R., Hill, E., Fu, Z., Bian, E. J., Kinkaid, M. M., Villanueva, P., Weybright, A., Terrell, W., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01362-3 · Cited by 19 · see citing works

CSF total tau as a proxy of synaptic degeneration

Soares, C., Bellaver, B., Ferreira, P. C. L., Povala, G., Aguzzoli, C. S., Ferrari‐Souza, J. P., Zalzale, H., Lussier, F. Z., Rohden, F., Abbas, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63545-5 · Cited by 15 · see citing works

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease

Montoliu‐Gaya, L., Bian, S., Dammer, E. B., Alcolea, D. A., Sauer, M., Martá-Ariza, M., Ashton, N. J., Belbin, O., Fuchs, J., Watson, C. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61054-z · Cited by 14 · see citing works

Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk

Huang, Y.-N., Liu, S., Park, T., Chaudhuri, S., Kuchenbecker, L. A., Carrasquillo, M. M., Ertekin‐Taner, N., Bice, P. J., Zetterberg, H., Blennow, K., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70579 · Cited by 13 · see citing works

Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes

Mei, Z., Liu, J., Bennett, D. A., Seyfried, N., Wingo, A. P., & Wingo, T. S. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70206 · Cited by 11 · see citing works

Rapid and simple separation and detection of Aβ42 in blood neuronal-derived extracellular vesicles using nanozyme-catalyzed colorimetric sensor

Zhang, J., Zhao, Y., Li, X., Gu, M., Xu, L., Zhao, J., & Zhang, H. (2025) · Talanta · doi:10.1016/j.talanta.2025.128439 · Cited by 11 · see citing works

Global analysis of the heparin-enriched plasma proteome captures matrisome-associated proteins in Alzheimer’s diseasePreprint

Guo, Q. J., Ping, L., Dammer, E. B., Duong, D. M., Yin, L., Xu, K., Shantaraman, A., Fox, E. J., Johnson, E. C. B., Roberts, B. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.06.565824 · Cited by 11 · see citing works

Systematic proteomics in Autosomal dominant Alzheimer’s disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathwaysPreprint

Shen, Y., Ali, M., Timsina, J., Wang, C., Do, A. N., Western, D., Liu, M., Gorijala, P., Budde, J., Liu, H., et al. (2024) · medRxiv · doi:10.1101/2024.01.12.24301242 · Cited by 10 · see citing works

Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study

Rehman, H., Ang, T. F. A., Tao, Q., Au, R., Farrer, L. A., Qiu, W. Q., Zhang, X., & Initiative, A. D. N. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70066 · Cited by 9 · see citing works

A FRET Autophagy Imaging Platform by Macrocyclic Amphiphile

Jiang, Z.-T., Chen, J., Chen, F., Cheng, Y., Yao, S., Ma, R., Li, W., Chen, H., & Guo, D. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202420793 · Cited by 8 · see citing works

Diet, gut-brain axis, and metabolism-epigenome-immunity networks: A triad in neurological disease management

Fan, Y., Xiao, B., Zhou, H., Liu, Z., Wang, L., Jin, W., Yin, Y., & Mao, X. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108031 · Cited by 7 · see citing works

Multi-Scale Integration of Human Brain Vascular and CSF Proteomes Reveals Biomarkers of Cerebral Amyloid Angiopathy Linked to Alzheimer’s Disease RiskPreprint

Wojtas, A., Rathore, S., Dammer, E. B., Yu, L., Seifar, F., Gadhavi, J. D., Shantaraman, A., Duong, D. M., Wu, F., Liu, Y., et al. (2025) · medRxiv · doi:10.1101/2025.10.08.25337413 · Cited by 8 · see citing works

Blood proteomics for quantitative biomarkers of cellular therapies

Gafken, P. R., & Paczesny, S. (2025) · Biomarker Research · doi:10.1186/s40364-025-00837-4 · Cited by 6 · see citing works

Blood protein markers predict 15-year risk of dementia

(2024) · Nature Aging · doi:10.1038/s43587-023-00566-z · Cited by 5 · see citing works

Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Clinical and Neuropathological HeterogeneityPreprint

Higginbotham, L. A., Rathore, S., Shantaraman, A., Guo, Q., Fox, E. J., Bagchi, P., Wu, F., Denkinger, M. N., Hanley, D., Ashton, N. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.658994 · Cited by 5 · see citing works

Current trends in advanced imaging modalities for the early diagnosis of Alzheimer's disease

Zhang, X., & Xue, P. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111628 · Cited by 4 · see citing works

Proteins sensing of plasma-derived extracellular vesicles in Alzheimer’s disease based on primer exchange reaction amplification strategy

Zhang, J., Lv, M., Zhao, Y., Zhang, L., Zhang, L., & Zhang, H. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111978 · Cited by 4 · see citing works

Mendelian Randomization Estimates the Effects of Plasma and Cerebrospinal Fluid Proteins on Intelligence, Fluid Intelligence Score, and Cognitive Performance

Zhao, W., Zhang, X., Li, F., & Cheng, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04542-5 · Cited by 2 · see citing works

Unveiling Potential Biomarkers in Cerebrospinal Fluid for Amyloid Pathological Positivity in Non-Demented Individuals

Meng, F., & Zhang, X. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.129 · Cited by 4 · see citing works

Synaptic protein CSF levels relate to memory scores in individuals without dementia

Wesenhagen, K. E. J., de Leeuw, D. M., Tomassen, J., Gobom, J., Bos, I., Vos, S. J. B., Martínez‐Lage, P., Tainta, M., Popp, J., Peyratout, G., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01703-z · Cited by 4 · see citing works

Multiomic Evidence for a Unified Model of Alzheimer’s Disease Etiology Linking Microglial Flux Capacity and Astrocyte-Neuron Metabolic BreakdownPreprint

Paterson, T., Rohrs, J. A., Hohman, T. J., Mapstone, M. E., Meikle, P. J., Kaddurah‐Daouk, R., Levey, A. I., Hood, L., Initiative, A. D. N., & Funk, C. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.23.604835 · Cited by 3 · see citing works

A compilation of reported alterations in the cerebrospinal fluid proteome in Alzheimer's disease

de Geus, M. B., Nairn, A. C., Arnold, S. E., & Carlyle, B. C. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf202 · Cited by 3 · see citing works

Advances in Diagnostics and Treatments for Alzheimer’s Disease

Sunderland, A., Thatcher, A. L., Rackley, E. V., & Kuruvilla, T. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2025.0492 · Cited by 4 · see citing works

Proteins Associated with Cognition in Amyloid-beta Positive Elders Based on Cerebrospinal Fluid Proteomics

Liu, M., Hu, H., Fu, Y., Chi, H., Huang, L.-Y., Tan, L., & Hu, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05442-y · Cited by 2 · see citing works

Plasma proteomic signatures associate with near-future Alzheimer’s disease dementia conversion in mild cognitive impairment patients

Xi, J., He, K., Hou, L., Smets, B., Miller, S., Saad, Z. S., Whelan, C. D., Ruiz, A., Puerta, R., Cano, A. C., et al. (2026) · npj Dementia · doi:10.1038/s44400-025-00053-9 · Cited by 4 · see citing works

Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns

Hou, X., Zhang, W., Kang, K., Jin, Y., Ren, P., Wang, L., Li, Z., Li, Y., You, J., Zhang, B., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71106 · Cited by 2 · see citing works

Ultrasensitive Saliva-Based Detection of Early Alzheimer’s Disease Biomarkers via Nanoparticle-Enhanced Evanescent Scattering Microscopy

Dallari, C., Ladurner, G., Kendrisic, M., Caria, F. F., Manzl, C., Ponticelli, L., Perego, L., Goretti, F., Credi, C., Prokesch, M., et al. (2026) · ACS Sensors · doi:10.1021/acssensors.5c04842 · Cited by 2 · see citing works

Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025)

Kanoria, S., Veitch, D. P., Miller, M. J., Aisen, P. S. S., Beckett, L. A., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Lee, E. B., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71353 · Cited by 2 · see citing works

CSF proteomics and machine learning reveal distinct stages across the Alzheimer’s disease continuum

Rathore, S., Dammer, E. B., Shantaraman, A., Wu, F., Duong, D. M., Fox, E. J., Johnson, E. C. B., Lah, J. J., Initiative, A. D. N., Levey, A. I., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00983-9 · Cited by 2 · see citing works

In‐Depth Cell‐Type‐Specific Proteome Landscape of the Brain from Human Amyloid‐β Overexpression Mouse Model

Ryu, T., Kim, S., Thuraisamy, T., Shin, J., Jang, Y., Kam, T., & Na, C. H. (2025) · Advanced Science · doi:10.1002/advs.202409318 · Cited by 1 · see citing works

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Hu, M., Robinson, O., Lill, C. M., Matton, A., Puerta, R., Sánz, P., Boada, M., Ruiz, A., Middleton, L. T., & Initiative, T. A. D. N. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70227 · Cited by 1 · see citing works

Regulation of granin neuropeptide gene expression in human brain during development

Demsey, L. L., Podvin, S., & HOOK, V. Y. H. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1666795 · Cited by 1 · see citing works

Nutritional substrates and microglial metabolic fitness in brain aging and Alzheimer's disease: from lipid handling to TREM2-linked translation

Li, Z., Ming, Q., Fu, L., Yang, J., Lv, Y., Chen, B., & Lu, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1886340 · Cited by 1 · see citing works

Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum

Xu, B., Ling, Y., Liu, L., Liu, Y., Lin, Y., Lyu, J., & Zhang, Y. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05104-z · Cited by 1 · see citing works

Bridging Health Disparity Gaps in Alzheimer’s Disease among Marginalized Populations: Clinical Proteomics as a Case Study

Adeola, H. A., & Robinson, R. A. S. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.5c00074 · Cited by 1 · see citing works

Cerebrospinal fluid proteomics for predictive assessment of Alzheimer’s Disease riskPreprint

Rathore, S., Dammer, E. B., Shantaraman, A., Wu, F., Duong, D. M., Fox, E. J., Johnson, E. C. B., Lah, J. J., Initiative, A. D. N., Seyfried, N. T., et al. (2025) · medRxiv · doi:10.1101/2025.10.24.25337921 · Cited by 1 · see citing works

Predicting Alzheimer’s Disease Diagnosis, a Decade or more Years before Onset using the Electronic Health Record and Random Forest Machine Learning ModelsPreprint

Taneja, S. B., Boyce, R. D., Malec, S. A., Albert, S. M., Shaaban, C. E., Levine, A. S., Munro, P., Bian, J., Xu, J., Maraganore, D., et al. (2025) · medRxiv · doi:10.1101/2025.11.04.25338396 · Cited by 1 · see citing works

Protein Panel in Cerebrospinal Fluid Helps Diagnose Alzheimer's and Track Progression

Talan, J. (2023) · Neurology Today · doi:10.1097/01.nt.0000992928.75709.08

Additional file 1 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients

Vervuurt, M., Schrader, J. M., de Kort, A. M., Kersten, I., Wessels, H. J. C. T., Klijn, C. J. M., Schreuder, F. H. B. M., Kuiperij, H. B., Gloerich, J., Nostrand, W. E. V., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24965944

BNIP1 inhibits the fusion of autophagosome and lysosome in hippocampal neurons and promotes the development of Alzheimer's diseasePreprint

Li, C., Zhang, M., Xia, H., Zhi, X., Wang, N., Long, Y., Yuan, Y., Shen, Y., Wang, L., & Wang, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4455991/v1

A FRET Autophagy Imaging Platform by Macrocyclic Amphiphile

Jiang, Z.-T., Chen, J., Chen, F., Cheng, Y., Yao, S., Ma, R., Li, W., Chen, H., & Guo, D. (2024) · Angewandte Chemie · doi:10.1002/ange.202420793

Additional file 4 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Shantaraman, A., Dammer, E. B., Ugochukwu, O., Duong, D. M., Yin, L., Carter, E. K., Gearing, M., Chen-Plotkin, A., Lee, E. B., Trojanowski, J. Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26758102

Additional file 2 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Shantaraman, A., Dammer, E. B., Ugochukwu, O., Duong, D. M., Yin, L., Carter, E. K., Gearing, M., Chen-Plotkin, A., Lee, E. B., Trojanowski, J. Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26507275

Additional file 2 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients

Vervuurt, M., Schrader, J. M., de Kort, A. M., Kersten, I., Wessels, H. J. C. T., Klijn, C. J. M., Schreuder, F. H. B. M., Kuiperij, H. B., Gloerich, J., Nostrand, W. E. V., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24966090

Additional file 1 of Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum

Xu, B., Ling, Y., Liu, L., Liu, Y., Lin, Y., Lyu, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25989206

Additional file 1 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Shantaraman, A., Dammer, E. B., Ugochukwu, O., Duong, D. M., Yin, L., Carter, E. K., Gearing, M., Chen-Plotkin, A., Lee, E. B., Trojanowski, J. Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26507230

Additional file 3 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Shantaraman, A., Dammer, E. B., Ugochukwu, O., Duong, D. M., Yin, L., Carter, E. K., Gearing, M., Chen-Plotkin, A., Lee, E. B., Trojanowski, J. Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26758099

Regional cerebral hypometabolism and pathological heterogeneity in sporadic early onset alzheimer’s disease: China Aging and Neurodegenerative Initiative (CANDI) study

Zhu, Z., Ni, M., Lv, X., Peng, J., Gao, F., Pan, B., Shen, Y., Wang, S., & Shi, J. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07798-2

Nanomaterials integrated with multiple technologies increase the diagnostic efficacy of biomarkers for neurological diseases: A narrative review

Qiu, J., Tao, L., & Li, P. (2026) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-25-00028

Role of Biomarker in Treating Alzheimer's Disease

Anand, P., Kumar, D., Gupta, S., Tiwari, J., & Singh, S. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010006

A Biomarker Out of Context: Understanding High p-tau217 in the Developing Brain

Pal, A., Yadav, H., Yadav, D., Goel, F., & Rajput, M. S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05968-9

THE RELATIONSHIP BETWEEN SCHIZOPHRENIA AND ALZHEIMER'S DISEASE - AN ATTEMPT TO A HOLISTIC VIEW OF NEURODEGENERATIVE DISORDERS

Korowacki, M., Wrzesińska, A., Rusin, I., Mączka, K., Grobecki, D., Kazimierczak, K., Przybylski, M., Kruczek, F., Dyczko, J., & Świrad, B. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.5858

Artificial intelligence in Alzheimer's disease: From clinical biomarker intelligence to therapeutic innovation

Wang, J., Li, Z., Wang, T., Jiang, L., Sharif, A., Takechi, R., Li, T., Chong, L. H., Fang, F., Pang, Z., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.013

CSF protein panels reflecting multiple pathophysiological mechanisms for early and specific diagnosis of Alzheimer’s disease

del Campo, M., Peeters, C. F. W., Johnson, E. C. B., Vermunt, L., Hok‐A‐Hin, Y. S., van Nee, M. M., Chen‐Plotkin, A. S., Hu, W. T., Lah, J. J., Seyfried, N. T., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.053710

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

del Campo, M., Peeters, C. F. W., Johnson, E. C. B., Vermunt, L., Hok‐A‐Hin, Y. S., van Nee, M. M., Chen‐Plotkin, A. S., Irwin, D. J., Hu, W. T., Lah, J. J., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00300-1 · Cited by 97 · see citing works

Cerebrospinal fluid proteomics for predictive assessment of Alzheimer’s Disease riskPreprint

Rathore, S., Dammer, E. B., Shantaraman, A., Wu, F., Duong, D. M., Fox, E. J., Johnson, E. C. B., Lah, J. J., Initiative, A. D. N., Seyfried, N. T., et al. (2025) · medRxiv · doi:10.1101/2025.10.24.25337921 · Cited by 1 · see citing works

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

Craig‐Schapiro, R., Kühn, M., Xiong, C., Pickering, E. H., Liu, J., Misko, T. P., Perrin, R. J., Bales, K. R., Soares, H. D., Fagan, A. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018850 · Cited by 235 · see citing works

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease

Guo, Y. X., Chen, S.-D., You, J., Huang, S.-Y., Chen, Y., Zhang, Y., Wang, L., He, X., Deng, Y., Zhang, Y.-R., et al. (2024) · Nature Human Behaviour · doi:10.1038/s41562-024-01924-6 · Cited by 65 · see citing works